Imatinib vs Rituximab
Imatinib vs Rituximab: Overview
This comparison examines the pharmacological differences between Imatinib and Rituximab.
Mechanism of Action
Imatinib: Selective inhibitor of BCR-ABL, c-Kit, and PDGFR tyrosine kinases.
Rituximab: Chimeric anti-CD20 IgG1 monoclonal antibody inducing B-cell depletion via CDC, ADCC, and apoptosis.
Pharmacokinetics
Half-life: Imatinib — 18 hours; Rituximab — 22 days.
Chemical Properties
Molecular Formula: Imatinib — C29H31N7O.
Molecular Weight: Imatinib — 493.6030 g/mol.
Type: Imatinib — Small molecule; Rituximab — Antibody.